Related Experiment Video
Updated: Aug 5, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Abstract:
Normal haemostasis depends on a balance between coagulation and fibrinolytic processes. Because of this concept of balance between coagulation and fibrinolysis, drugs which retard or inhibit the breakdown of fibrin encourage haemostasis. Such drugs are used in patients undergoing dental extractions and as prophylactic agents to prevent spontaneous bleeding. Blood clotting factors produced by genetic engineering are now becoming available and these offer exciting prospects for the management of patients with bleeding disorders.
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

